Etanercept Responsive Acrodermatitis Continua of Hallopeau: Is a Pattern Developing?
October 2006 | Volume 5 | Issue 9 | Case Reports | 903 | Copyright © October 2006
Brian Bonish MD PhD, Rashid M. Rashid PhD, James Swan MD
AbstractAcrodermatitis continua of Hallopeau (ACH) is a rare disease. Little is known about its etiology or relative effectiveness of the various therapeutic approaches. However, in the literature a pattern seems to be developing on successfully treated patients using biologic therapies. Here, we further emphasize the potential breakthrough presented by the novel immune based therapies. This report consists of a case of etanercept responsive ACH along with a brief review of the literature.